Director received an award of 791 WST shares | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- May 4, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- May 6, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000105770-26-000062
- Filed / recorded
May 6, 2026, 9:30 PM UTCAdded to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerWEST PHARMACEUTICAL SERVICES INC Reporting personDeborah L Keller TableNon-derivative (Table I) Transaction dateMay 4, 2026 Acquired / disposedAcquired (A) Shares owned after11,560.479 Footnotes from the filing
- These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.